Testosterone and cognitive function: current clinical evidence of a relationship
- PMID: 17132744
- DOI: 10.1530/eje.1.02306
Testosterone and cognitive function: current clinical evidence of a relationship
Abstract
Background: Testosterone levels decline as men age, as does cognitive function. Whether there is more than a temporal relationship between testosterone and cognitive function is unclear. Chemical castration studies in men with prostate cancer suggest that low serum testosterone may be associated with cognitive dysfunction. Low testosterone levels have also been observed in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). This paper reviews the current clinical evidence of the relationship between serum testosterone levels and cognitive function in older men.
Methods: A systematic literature search was conducted using PubMed and EMBASE to identify clinical studies and relevant reviews that evaluated cognitive function and endogenous testosterone levels or the effects of testosterone substitution in older men.
Results: Low levels of endogenous testosterone in healthy older men may be associated with poor performance on at least some cognitive tests. The results of randomized, placebo-controlled studies have been mixed, but generally indicate that testosterone substitution may have moderate positive effects on selective cognitive domains (e.g. spatial ability) in older men with and without hypogonadism. Similar results have been found in studies in patients with existing AD or MCI.
Conclusions: Low endogenous levels of testosterone may be related to reduced cognitive ability, and testosterone substitution may improve some aspects of cognitive ability. Measurement of serum testosterone should be considered in older men with cognitive dysfunction. For men with both cognitive impairment and low testosterone, testosterone substitution may be considered. Large, long-term studies evaluating the effects of testosterone substitution on cognitive function in older men are warranted.
Similar articles
-
Role of testosterone in cognition and mobility of aging men.Andrology. 2020 Nov;8(6):1567-1579. doi: 10.1111/andr.12872. Epub 2020 Aug 31. Andrology. 2020. PMID: 32700462 Review.
-
A Review on the Effects of Testosterone Supplementation in Hypogonadal Men with Cognitive Impairment.Curr Drug Targets. 2018;19(8):898-906. doi: 10.2174/1389450118666170913162739. Curr Drug Targets. 2018. PMID: 28914204 Review.
-
Cognitive effects of testosterone and finasteride administration in older hypogonadal men.Clin Interv Aging. 2014 Aug 12;9:1327-33. doi: 10.2147/CIA.S61760. eCollection 2014. Clin Interv Aging. 2014. PMID: 25143719 Free PMC article. Clinical Trial.
-
Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.J Androl. 2007 Nov-Dec;28(6):875-82. doi: 10.2164/jandrol.107.002931. Epub 2007 Jul 3. J Androl. 2007. PMID: 17609296 Clinical Trial.
-
Androgens and cognitive function.J Endocrinol Invest. 2005;28(3 Suppl):65-75. J Endocrinol Invest. 2005. PMID: 16044582 Review.
Cited by
-
A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer's Disease Risk in Older Men with Prostate Cancer.Degener Neurol Neuromuscul Dis. 2024 May 17;14:33-46. doi: 10.2147/DNND.S445130. eCollection 2024. Degener Neurol Neuromuscul Dis. 2024. PMID: 38774717 Free PMC article. Review.
-
Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077. Medicina (Kaunas). 2023. PMID: 38256338 Free PMC article. Review.
-
Effects of testosterone enanthate on aggression, risk-taking, competition, mood, and other cognitive domains during 28 days of severe energy deprivation.Psychopharmacology (Berl). 2024 Mar;241(3):461-478. doi: 10.1007/s00213-023-06502-8. Epub 2023 Dec 1. Psychopharmacology (Berl). 2024. PMID: 38038817 Free PMC article. Clinical Trial.
-
A review of the objective cognitive function measurements in males receiving hormonal therapy for prostate cancer.Investig Clin Urol. 2023 Nov;64(6):521-540. doi: 10.4111/icu.20230103. Investig Clin Urol. 2023. PMID: 37932563 Free PMC article. Review.
-
Cognitive Dysfunction in Patients Treated with Androgen Deprivation Therapy: A Multimodality Functional Imaging Study to Evaluate Neuroinflammation.Prostate Cancer. 2023 Oct 18;2023:6641707. doi: 10.1155/2023/6641707. eCollection 2023. Prostate Cancer. 2023. PMID: 37885823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources